neutral
Recently
Health and neuroscience startups secure major AI-focused funding rounds
SciNeuro Pharma and Paradigm Health closed sizable AI-driven funding rounds, strengthening investment momentum in computational neuroscience and digital health technology.
AI-driven innovation in healthcare accelerated as SciNeuro Pharma raised $53 million to advance computational neuro tools designed for early-stage discovery workflows. Paradigm Health secured a $78 million Series B round to expand AI-enabled diagnostics, clinical insights, and patient-support platforms.